Dr. Scheffer C. G. Tseng co-founded BioTissue and is currently Chief Technology Officer. Dr. Tseng is a world-renowned surgeon in ocular surface reconstruction and a widely published physician scientist with more than 380 peer-reviewed clinical and scientific papers. He pioneered limbal stem cell transplantation and developed and commercialized the CRYOTEK process to preserve the natural therapeutic properties of amniotic membrane. His research focus for the past 35 years has been to identify the active biological components of human placental tissues, to develop alternative products to deliver their therapeutic properties, and to expand their clinical applications. Dr. Tseng holds a medical degree from National Taiwan University and a Doctorate in Experimental Pathology from the University of California. He completed his residency in ophthalmology at the Wilmer Eye Institute at Johns Hopkins, and his fellowship in cornea and external diseases at Massachusetts Eye and Ear Infirmary. Prior to co-founding TissueTech, Dr. Tseng was a Chair Professor at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.